严重疾病后肌肉衰弱:解开生物机制和临床障碍
Alexandre Pierre1,2, Raphael Favory3,4, Claire Bourel3,4
1Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Facteurs de Risque Et Déterminants Moléculaires Des Maladies Liées Au Vieillissement, 59000, Lille, France. alexandre.pierre@univ-lille.fr.
Critical care (London, England)
|June 17, 2025
概括
重症监护室 (ICU) 的幸存者经常因为复杂的生物变化而经历持续的肌肉衰弱. 了解这些机制对于开发有效的治疗方法来实现长期的身体恢复至关重要.
科学领域:
- 关键护理医学 关键护理医学
- 生理学 生理学 生理学
- 分子生物学分子生物学
背景情况:
- 改善的医院护理增加了重症监护室 (ICU) 的幸存者数量.
- 后重症监护综合征 (PICS) 显著恶化了长期预后.
- 减少肌肉力量,质量和功能是幸存者的主要特征,导致残疾和死亡率增加.
研究的目的:
- 审查ICU幸存者的持续肌肉功能障碍的临床,生理和生物决定因素.
- 探索导致ICU后肌肉衰弱的分子,细胞和系统机制.
- 讨论创新的治疗方法和未来的研究方向.
主要方法:
- 这篇叙事综述综合了现有的关于ICU获得的肌肉虚弱的文献.
- 它检查了影响康复的因素,包括ICU前的健康状况,ICU并发症和ICU后的管理.
- 该审查重点关注起作用的生理和生物机制.
主要成果:
- 在ICU幸存者的肌肉衰弱是由神经内分泌,血管,神经和肌肉系统功能障碍驱动的.
- 复杂的生物机制包括线粒体和自功能障碍,表观遗传变化,细胞衰老,炎症,免疫细胞功能障碍,干细胞枯竭和细胞外矩阵重塑.
- 预先存在的疾病 (肥胖,) 和ICU干预影响康复.
结论:
- 后ICU肌肉衰弱是一个动态的,多方面的问题,需要一个整体的方法.
- 结合营养,身体和生物干预的综合治疗方法显示出有前途.
- 从ICU入院到ICU后康复,解决这些因素对于减轻长期身体残疾至关重要.
相关概念视频
Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Myasthenia Gravis: Diagnostic Tests
1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Chemical Synapses
9.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.2K
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Muscle Recovery and Fatigue
2.6K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.6K
Skeletal Muscle Relaxants: Adverse Effects
485
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
485


